Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Elisa Passini, a postdoctoral research assistant from the Computational Cardiovascular Science group, which is part of CRE, has officially been awarded the 2017 international prize from the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs).

The £30k award, which is sponsored by GSK, was presented to Elisa in London on the evening of 12th March 2018, by Sir Mark Walport, the Chief Executive Designate of UK Research and Innovation.

Awarded annually, the NC3Rs prize highlights an outstanding and original contribution to scientific and technological advances in the 3Rs. 

The 2017 award recognised Elisa's research with colleagues and Janssen Pharmacaeutica, conducted in Professor Blanca Rodriguez and Dr Alfonso Bueno-Orovio’s group at the University of Oxford’s Department of Computer Science, on an in silico model that predicts cardiotoxicity more accurately than animal studies. 

The winning paper, published in Frontiers in Physiology, describes a drug trial, where 62 drugs and reference compounds were tested at various concentrations in more than a thousand simulations of human heart cells; the computer model predicted risk with 89% accuracy, whereas previous studies on animals had shown 75% accuracy. 

Early predictions of possible heart problems is massively important for drug development, given that 40% of drugs withdrawn from the market between 2001 and 2010 had cardiovascular safety issues. 

Estimates suggest that more than 60,00 animals are used globally to asses drug risk to cardiac safety, and so computational models such as that developed by Elisa and her colleagues could reduce this number dramatically. 

You can hear Elisa's thoughts on winning the award in the video below.

 

Similar stories

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.

Study indicates reasons for decline in death rates from heart attacks

A new study involving Oxford Population Health researchers finds that both prevention and improved treatments have helped reduce deaths from heart attacks - but the relative importance of each varies by country, age and sex.

Review highlights impact of Long COVID on cardiovascular system

The wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID on the cardiovascular system.

Commercial development of therapeutic anti-inflammatory peptide begins

An Oxford BHF CRE “Pump Priming” award to Professor Shoumo Bhattacharya and his research group led to a great return on investment with this exclusive licensing agreement for their innovative research.

London Marathon to fund De Val and Vieira Lab research as two of eight handpicked BHF projects

Two projects aimed at tackling heart failure led by Associate Professor Sarah De Val and Dr Joaquim Vieira are to be funded by the 2022 TCS London Marathon with the British Heart Foundation as its Charity of the Year. The BHF’s runners, who are raising £3 million in funding, will include De Val Lab postdoctoral researcher Dr Alice Neal.

Dr Qiang Zhang wins Society for Cardiovascular Magnetic Resonance Early Career Award 2022

Many congratulations to Dr Qiang Zhang, Oxford BHF CRE Transition Fellow, who has won a prestigious award for his work in developing a groundbreaking technology for detecting scar in the myocardium